Why Bayer's Worst Years Might Be The Start Of Its Comeback

Group 1 - The analysis focuses on high-quality companies that can outperform the market over the long run due to competitive advantages and high levels of defensibility [1] - The analyst has previously published articles on Bayer Aktiengesellschaft, expressing a bullish outlook in both March 2025 and December 2024 [1] - The focus is primarily on European and North American companies, without constraints regarding market capitalization [1] Group 2 - The analyst holds a beneficial long position in Bayer Aktiengesellschaft shares through stock ownership, options, or other derivatives [2] - The article reflects the analyst's own opinions and is not influenced by compensation from any company mentioned [2]